iBio, Inc.IBIONYSE
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+7.9%
5Y CAGR+5.3%
Year-over-Year Change
Research and development spending
3Y CAGR
+7.9%/yr
vs +17.2%/yr prior
5Y CAGR
+5.3%/yr
Consistent
Acceleration
-9.3pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.3x
Solid growth
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $12.96M | +55.9% |
| 2025 | $8.31M | +60.3% |
| 2024 | $5.18M | -49.8% |
| 2023 | $10.33M | +5.1% |
| 2022 | $9.83M | -1.6% |
| 2021 | $9.99M | +179.6% |
| 2020 | $3.57M | -34.7% |
| 2019 | $5.47M | +37.3% |
| 2018 | $3.99M | -3.2% |
| 2017 | $4.12M | - |